Followers | 260 |
Posts | 51522 |
Boards Moderated | 11 |
Alias Born | 08/29/2007 |
Sunday, January 07, 2024 11:59:45 AM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent INMB News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:05:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:30:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:00:11 PM
- INmune Bio Inc. to Join Russell 3000® Index • GlobeNewswire Inc. • 05/30/2024 12:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/29/2024 08:05:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:00:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 08:10:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 08:10:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 08:08:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 08:08:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 08:07:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 08:00:14 PM
- INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 08:05:36 PM
- INmune Bio Inc. to Report First Quarter 2024 Financial Results and Provide a Corporate Update on Thursday, May 9 • GlobeNewswire Inc. • 05/07/2024 12:00:00 PM
- INmune Bio Inc. Provides Update on Two Patients from the Phase 1b Alzheimer’s Disease Trial who Continue to Receive XPro™ Under Compassionate Use for Over Three Years • GlobeNewswire Inc. • 04/30/2024 12:00:00 PM
- INmune Bio Inc. Completes First Cohort and Initiates Second Cohort of Phase 1/2 Study of INKmune™ Natural Killer Cell Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer • GlobeNewswire Inc. • 04/29/2024 12:00:00 PM
- INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 04/25/2024 01:00:00 PM
- INmune Bio Inc. Announces 24-Month Stability Validation of XPro™ for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay • GlobeNewswire Inc. • 04/23/2024 12:00:00 PM
- INmune Bio Inc. Raises Approximately $4.8 Million in Gross Proceeds Through Registered Direct Offering with Officers, Employees and Directors Purchasing Approximately 20% of the Offering • GlobeNewswire Inc. • 04/22/2024 12:00:00 PM
- INmune Bio Inc. Presents Data on INB03’s Role as an Immune Check Point Modulator in the Treatment of High-Risk Breast Cancer at AACR 2024 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- INmune Bio Inc. Announces Year End 2023 Results and Provides a Q4 Business Update • GlobeNewswire Inc. • 03/28/2024 08:01:53 PM
- INmune Bio Inc. to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Thursday, March 28 • GlobeNewswire Inc. • 03/26/2024 08:01:00 PM
- INmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives The ISCT Career Achievement Award in Cell and Gene Therapy • GlobeNewswire Inc. • 03/13/2024 12:00:00 PM
- INmune Bio Reports Significant EEG Improvement in Alzheimer’s Patients Treated with XPro™ • GlobeNewswire Inc. • 03/05/2024 01:00:00 PM
- INmune Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/12/2024 02:00:00 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM